ACDIMA BioCenter is a comprehensive clinical CRO based in Jordan, founded in 2000 as a multinational, business-driven investment supporting the clinical trials and bioequivalence studies industry to help expedite regulatory approval. Over more than 22 years, ACDIMA BioCenter has completed more than 1,000 studies, including PK bioavailability and bioequivalence studies, drug-drug interaction studies and palatability studies.
댓글이 없습니다.
평가 & 댓글 남기기